Health Tech lead generation that finds decision-makers.
BeReach reads the public signals digital health companies leave behind, like funding rounds, product launches, regulatory milestones and hiring. It qualifies each company against your ICP, then helps you reach the right decision-maker with a warm, contextual message.
1,000+ teams4.9| # | Name | Conn | Signal |
|---|---|---|---|
| 1 |  Dr Amara Osei Chief Medical Officer · Caremesh | 2nd | Liked the post |
| 2 |  Thomas Reinhardt VP Product · Vitalflow | 2nd | Commented |
| 3 |  Isabel Moreno Head of Clinical Ops · Lumen Health | 3rd | Commented |
| 4 | Kevin Tanaka Founder · Pulsewell | 2nd | Reposted |
| 5 | Rachel Adeyemi Growth Lead · Nurova | 3rd | Liked the post |
Health tech signals
funding, launches, clearances, hiring
Typical acceptance rate
warm, contextual first touch
Typical reply rate
vs generic cold outreach
To a qualified list
any segment, any stage
Your agent scans where these accounts actually show up: funding and launch data, reviews and traction, tech stacks, hiring posts, and the people behind them.
Every account is scored against your ideal profile on size, stage, traction and buying signals, so noise is filtered out before it ever reaches you.
For each qualified account, the agent finds the right decision-maker and helps you send a contextual message that references a real signal, not a generic template.
Know exactly when a digital health company raises, who led it, and how much. A freshly funded team is actively buying tools and partners, so you can reach them while the budget is fresh.
Clearances and compliance announcements mark a company entering a new phase. Reach the commercial or clinical lead while priorities and budgets are shifting.
New platforms, features and integrations show a team in motion. Lead with a reason tied to what they just shipped, not a cold pitch.
A company posting commercial, clinical or payer partnership roles is scaling. Track hiring to find teams in active growth mode, the ones most likely to buy.
BeReach reads the public web in real time, across funding data, product launches, regulatory announcements, job boards and public profiles, then cross-references them to surface qualified companies along with the actual decision-maker's name and how to reach them. It is live signal, not a quarterly database dump. All targeting is B2B, focused on operators and buyers reachable on LinkedIn.
Legacy databases index enterprise firmographics and refresh slowly, so digital health startups and vertical care platforms are under-covered or missing entirely. BeReach searches the real-time sources where health tech companies actually announce themselves, like funding, launches, clearances and hiring, so it finds accounts those databases do not have.
Yes. Every lead is built from public signals across the open web, cross-referenced and verified. There is no scraping behind a login and no private database. BeReach targets business decision-makers and operators, not patients or protected health information.
Funding stage and recency, product launches, regulatory and compliance milestones, headcount and hiring activity. You describe your ICP in plain language and the agent scores each company against it, so only the strong-fit ones reach you.
Yes, and that is the difference from a list tool. After the Finder surfaces companies and the Qualifier scores them, the Reacher helps you open a warm, multichannel conversation with the right person, referencing a real signal like a recent raise or a new clearance instead of a generic template.
Yes. Just describe what you want, like a Series A telehealth platform in the US hiring a Head of Payer Partnerships, and the agent handles the combination of stage, segment, role and buying signals. No filters or boolean syntax to learn.
Usually under two minutes. Describe the companies you want, the agent scans the public sources, qualifies them against your ICP, and returns a list with named decision-makers ready to reach out to.
The all-in-one AI SDR was supposed to replace your sales team. By early 2026, most companies that tried it have gone back to hybrid models. Here's what AI agents actually do well for LinkedIn prospecting - and where the hype still outpaces reality.
Alexandre Sarfati
Companies doing LinkedIn ABM well generate $10+ in pipeline per dollar spent and 44% higher ROAS than Google. But most ABM on LinkedIn fails because teams treat it like targeted cold outreach. Here's what the data shows actually works.
Alexandre Sarfati
Belkins analyzed over 20 million LinkedIn outreach attempts across 13,000 accounts. Here's what the data says about cold versus warm approaches, which combinations work, and what most teams get wrong.
Alexandre Sarfati
Describe your ideal health tech account and let your agent find, qualify, and reach the decision-makers behind it.
Free credits inside · no credit card
Click a button and let your favorite AI weigh in.
